2024 Insights Report
Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2025 and how VytlOne clinical programs 
can help.
Resources
Real Data That Drives Impact
We provide insights with real data and real results and create blogs about pharmacy topics to educate and inspire you.
Insights (Case Studies, Clinical Info, Media & Reports)
In our second annual healthcare leadership report, 100 health system executives and pharmacy leaders…
In this edition, we’re leaning into new drug innovations, including Insmed’s new drug, Brinsupri…Â
In this edition, we feature new drugs to market, the clinical pipeline, and GLP-1 updates as well as a spotlight on Acute Myocardial Infarction…Â
Blogs and News
Blog
2025 drug approvals, breakthroughs, and trends
Summary The Food and Drug Administration (FDA) approved 46 novel drugs in 2025, four fewer ...
Read More →
Blog
What Were Key 340B Developments in 2025, and What’s Ahead for 2026?
Summary Significant 340B program changes in 2025 were driven by federal and state reforms, with ...
Read More →
Blog
What Changed for PBMs in 2025? 5 Trends and a 2026 Preview
Summary In 2025, PBMs adapted to the rapid growth and changing landscape of GLP-1 therapies ...
Read More →
Connect With Us
Want to connect with VytlOne explore opportunities? Get in touch with us today.